Komori
Governance4553TOWA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Articles of Incorporation 2026/06/24

The Articles of Incorporation were updated as of 24 June 2026. The document does not describe the specific changes or identify which provisions were changed from the previous version.

Worth reading
85Important
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit and Supervisory Committee
Number of directorsNo more than 8 directors excluding directors who are Audit and Supervisory Committee members, and no more than 5 directors who are Audit and Supervisory Committee members. Total: no more than 13 directors; number of outside directors: Not disclosed
Committee1
Audit and Supervisory Committee
Changes this time

The document only states that partial changes were made on 24 June 2026; the specific changes are not disclosed.

Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit and Supervisory Committee
Number of directorsNo more than 8 directors excluding directors who are Audit and Supervisory Committee members, and no more than 5 directors who are Audit and Supervisory Committee members. Total: no more than 13 directors; number of outside directors: Not disclosed
CommitteeAudit and Supervisory Committee (proportion of outside members: Not disclosed)
Changes this timeThe document only states that partial changes were made on 24 June 2026; the specific changes are not disclosed.
Items this document does not state (4)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

No specific reason for the changes is provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Articles of Incorporation 2026/06/24 | TOWA PHARMACEUTICAL CO.,LTD. (4553) timely disclosure | Komori